Central α2 adrenergic receptors and cholinergic-induced salivation in rats

Brain Research Bulletin

Volumn 59, Issue 5, 2003, Pages 383-386

  Takakura, Ana Carolina Thomaz ^a   Moreira, Thiago dos Santos ^a   Luca Jr , Laurival Antonio De ^a   Renzi, Antonio ^a   Menani, José Vanderlei ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Moxonidine; Parasympathetic; Pilocarpine; RX 821002; Salivary secretion; Yohimbine

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; KETAMINE; MOXONIDINE; PILOCARPINE; PRAZOSIN; YOHIMBINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNULATION; CONTROLLED STUDY; DRUG ANTAGONISM; LATERAL BRAIN VENTRICLE; MALE; MOUTH; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVA; SALIVATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BRAIN; IDAZOXAN; IMIDAZOLES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCARINIC AGONISTS; PILOCARPINE; PRAZOSIN; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; SALIVATION; SYMPATHOLYTICS; YOHIMBINE;

EID: 0037472350     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(02)00929-2     Document Type: Article

References (27)

1. 2 adrenergic receptors in the anti-hypertensive responses evoked by central administration of clonidine analogs in conscious spontaneous hypertensive rats. J. Pharmacol. Exp. Ther. 273:1995;1162-1171.
2. Elverdin J.C., Luchelli-Fortis M.A., Stefano F.J.E., Perec C.J. Alpha-1 adrenoceptors mediate secretory responses to norepinephrine in innervated and denervated rat submaxillary glands. J. Pharmacol. Exp. Ther. 229:1984;261-266.
3. Emmelin N. Nerve interactions in salivary glands. J. Dental Res. 66:1987;509-517.
4. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264:1993;172-264.
5. Ernsberger P., Elliot H.L., Weiman H.J., Raap A., Haxhiu M.A., Hofferber E., Low-Kroger A., Reid J.L., Mest H.J. Moxonidine: A second-generation central anti-hypertensive agent. Cardiovasc. Drug Rev. 11:1993;411-431.
6. 1-imidazoline receptor: From binding site to therapeutic target in cardiovascular disease. J. Hypertens. 15(suppl. 1):1997;S9-S23.
7. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. Am. J. Physiol. 273:1997;R1572-R1579.
8. 1-imidazoline agonist. Cardiovasc. Drug. Ther. 8:1994;27-41.
9. 2 adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134:1987;1-13.
10. Ferguson M.M. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg. Oral Med. Oral Pathol. 75:1993;186-191.
11. Garrett J.R. The proper role of nerves in salivary secretion: A review. J. Dental Res. 66:1987;387-397.
12. 2 adrenoceptor. Pharmacol. Rev. 35:1983;143-179.
13. Green G.J., Wilson H., Breckenridge A.M. Action of clonidine on centrally evoked salivation in anaesthetized cats. Clin. Sci. 57:1979;429S-431S.
14. Green G.J., Wilson H., Yates M.S. The mechanisms of the clonidine-induced reduction in peripheral parasympathetic submaxillary salivation. Eur. J. Pharmacol. 56:1979;331-336.
15. Izumi H., Nakamura I., Karita K. Effects of clonidine and yohimbine on parasympathetic reflex salivation and vasodilation in cat SMG. Am. J. Physiol. 268:1995;R1196-R1202.
16. Kaniucki M.D., Stefano F.J., Perec C.J. Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 326:1984;313-336.
17. 2A adrenoceptors Eur. J. Pharmacol. 167:1989;95-104.
18. Moreira T.S., Takakura A.C.T., De Luca L.A. Jr., Renzi A., Menani J.V. Moxonidine reduces pilocarpine-induced salivation in rats. Aut. Neurosci. Basic Clin. 91:2001;32-36.
19. Nurminen M.L., Culman J., Haass M., Chung O., Unger T. Effect of moxonidine on blood pressure and sympathetic tone in conscious spontaneously hypertensive rats. Eur. J. Pharmacol. 362:1998;61-67.
20. Rand M.J., Rush M., Wilson J. Some observations on the inhibition of salivation by St 155 [2-(2,6-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres, Catapressan]. Eur. J. Pharmacol. 5:1969;168-172.
21. Renzi A., Colombari E., Mattos Filho T.R., Silveira J.E.N., Saad W.A., Camargo L.A.A., De Luca L.A. Jr., Deróbio J.G., Menani J.V. Involvement of the central nervous system in the salivary secretion induced by pilocarpine in rats. J. Dental Res. 72:1993;1481-1484.
22. Renzi A., De Luca L.A. Jr., Menani J.V. Lesions of the lateral hypothalamus impair pilocarpine-induced salivation in rats. Brain Res. Bull. 58:2002;455-459.
23. Renzi A., Saad W.A., Camargo L.A.A., Silveira J.E.N., Menani J.V. Effect of septal lesions in the salivary secretion induced by intracerebroventricular (i.c.v.) injection of pilocarpine in rats. Soc. Neurosci. Abstr. 20:1994;1374. [Abstract].
24. Schachter M. Moxonidine: A review of safety and tolerability after 7 years of clinical experience. J. Hypertens. 17(suppl. 3):1999;S37-S39.
25. van Zwieten P.A. Centrally acting anti-hypertensive drugs: Present and future. Clin. Exp. Hypertens. 21:1999;859-873.
26. Webster J., Koch H.F. Aspects of tolerability of centrally acting anti-hypertensive drugs. J. Cardiovasc. Pharmacol. 27(suppl. 3):1996;S49-S54.
27. Wiseman L.R., Faulds D. Oral pilocarpine: A review of its pharmacological properties and clinical potential in xerostomia. Drugs. 49:1995;143-155.